Complete Filing Data
Corvus Pharmaceuticals, Inc. reported Net Income Loss of -$15.28 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Corvus Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$15.3M | -$62.3M | -$27.0M | -$41.3M | -$43.2M | -$6.0M | -$46.7M | -$46.9M | -$55.7M | -$36.4M | -$31.3M | -$161.0K |
| Operating Expenses | $43.0M | $27.5M | $23.4M | $32.6M | $38.6M | $43.8M | $48.9M | $49.2M | $56.5M | $37.0M | $13.8M | |
| Research And Development Expense | $33.7M | $19.4M | $16.5M | $24.5M | $29.1M | $31.8M | $38.0M | $38.6M | $46.3M | $29.4M | $11.4M | $38.0K |
| Operating Income Loss | -$43.0M | -$27.5M | -$23.4M | -$32.6M | -$38.6M | -$43.8M | -$48.9M | -$49.2M | -$56.5M | -$37.0M | -$13.8M | -$161.0K |
| General And Administrative Expense | $9.3M | $8.2M | $6.9M | $8.1M | $9.5M | $11.9M | $10.9M | $10.6M | $10.2M | $7.6M | $2.4M | $123.0K |
| Comprehensive Income Net Of Tax | -$14.9M | -$62.6M | -$27.4M | -$43.7M | -$41.4M | -$6.0M | -$46.6M | -$46.9M | -$55.7M | -$36.4M | -$31.4M | -$161.0K |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$17.0K | $65.0K | $66.0K | -$48.0K | -$7.0K | -$25.0K | $63.0K | $7.0K | -$2.0K | $6.0K | -$45.0K | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax | -$17.0K | $65.0K | $66.0K | -$48.0K | -$7.0K | -$25.0K | $63.0K | $7.0K | -$2.0K | $6.0K | -$45.0K | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $409.0K | -$386.0K | -$470.0K | -$2.4M | $1.9M | |||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$13.3M | -$59.1M | -$21.7M | -$31.3M | ||||||||
| Income Loss From Equity Method Investments | -$2.0M | -$3.2M | -$5.3M | -$10.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$10.2M | -$8.0M | $15.2M | -$40.2M | -$4.3M | -$5.7M | -$6.0M | -$6.5M | -$7.9M | -$14.8M | -$8.4M | -$8.3M | -$10.7M | -$11.8M | -$11.6M | $27.3M | -$9.8M | -$10.6M | -$12.9M | -$11.0M | -$11.0M | -$13.0M | -$11.6M | -$10.5M | -$10.5M | -$11.6M | -$14.3M | -$11.9M | -$12.7M | -$15.0M | -$16.0M | -$11.1M | -$10.3M | -$8.6M | -$6.3M | -$6.0M | -$3.2M | -$20.2M | -$1.9M | |
| Operating Expenses | $10.6M | $10.3M | $9.9M | $7.3M | $5.9M | $6.3M | $5.6M | $5.6M | $6.6M | $12.5M | $7.0M | $7.4M | $6.8M | $9.0M | $11.3M | $11.5M | $9.9M | $9.8M | $10.8M | $13.3M | $11.4M | $11.5M | $13.6M | $12.3M | $11.2M | $11.1M | $12.3M | $14.6M | $12.2M | $12.9M | $15.2M | $16.2M | $11.2M | $10.5M | $8.8M | $6.4M | $2.3M | $2.2M | ||
| Research And Development Expense | $8.5M | $7.9M | $7.5M | $5.2M | $4.1M | $4.1M | $4.0M | $4.0M | $4.6M | $10.4M | $4.9M | $5.1M | $7.0M | $9.1M | $8.2M | $6.6M | $7.9M | $10.2M | $9.0M | $10.6M | $9.4M | $8.4M | $9.7M | $12.1M | $10.7M | $12.4M | $13.5M | $7.7M | $7.1M | $5.4M | $2.5M | $2.0M | $1.9M | |||||||
| Operating Income Loss | -$10.6M | -$10.3M | -$9.9M | -$7.3M | -$5.9M | -$6.3M | -$5.6M | -$5.6M | -$6.6M | -$12.5M | -$7.0M | -$7.4M | -$9.0M | -$11.3M | -$11.5M | -$9.8M | -$10.8M | -$13.3M | -$11.5M | -$13.6M | -$12.3M | -$11.1M | -$12.3M | -$14.6M | -$12.9M | -$15.2M | -$16.2M | -$10.5M | -$8.8M | -$6.4M | -$3.1M | -$2.3M | -$2.2M | |||||||
| General And Administrative Expense | $2.1M | $2.4M | $2.5M | $2.0M | $1.8M | $2.2M | $1.6M | $1.7M | $2.0M | $2.1M | $2.1M | $2.3M | $2.1M | $2.2M | $3.3M | $3.2M | $2.9M | $3.1M | $2.5M | $3.0M | $2.9M | $2.8M | $2.5M | $2.5M | $2.2M | $2.8M | $2.7M | $2.8M | $1.7M | $1.0M | $606.0K | $327.0K | $290.0K | |||||||
| Comprehensive Income Net Of Tax | -$10.1M | -$7.9M | $15.2M | -$39.6M | -$4.3M | -$6.0M | -$6.1M | -$7.4M | -$7.7M | -$16.4M | -$10.0M | -$8.2M | -$10.7M | -$10.4M | -$11.6M | -$9.8M | -$10.6M | -$12.9M | -$11.0M | -$13.0M | -$11.6M | -$10.5M | -$11.6M | -$14.3M | -$12.7M | -$15.0M | -$16.1M | -$10.3M | -$8.6M | -$6.3M | -$3.2M | -$20.2M | -$1.9M | |||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $29.0K | -$19.0K | -$23.0K | $152.0K | $5.0K | -$15.0K | $5.0K | -$1.0K | $41.0K | $5.0K | -$54.0K | -$28.0K | -$2.0K | -$4.0K | $2.0K | -$41.0K | $10.0K | $14.0K | -$5.0K | $28.0K | $45.0K | -$15.0K | $19.0K | -$2.0K | $38.0K | $11.0K | -$23.0K | -$36.0K | $49.0K | $74.0K | $1.0K | |||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax | $29.0K | -$19.0K | -$23.0K | $152.0K | $5.0K | -$15.0K | $5.0K | -$1.0K | $41.0K | $5.0K | -$54.0K | -$28.0K | -$2.0K | -$4.0K | $2.0K | -$41.0K | $10.0K | $14.0K | -$5.0K | $28.0K | $45.0K | -$15.0K | $19.0K | $2.0K | ||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $59.0K | $125.0K | $57.0K | $465.0K | -$85.0K | -$293.0K | -$80.0K | -$933.0K | $88.0K | -$1.5M | -$1.6M | $146.0K | -$10.0K | $1.4M | ||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$9.8M | -$7.6M | $15.7M | -$39.5M | -$3.7M | -$5.9M | -$5.1M | -$5.2M | -$6.1M | |||||||||||||||||||||||||||||||
| Income Loss From Equity Method Investments | -$323.0K | -$389.0K | -$539.0K | -$682.0K | -$577.0K | $236.0K | -$865.0K | -$1.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $61.2M | $32.6M | $38.7M | $56.1M | $97.2M | $72.1M | $71.1M | $110.3M | $84.8M | $132.8M | -$31.1M | -$159.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.6M | $8.7M | $12.6M | $13.2M | $63.5M | $16.5M | $5.2M | $39.2M | $45.1M | $5.1M | $4.1M | |
| Cash And Cash Equivalents At Carrying Value | $4.6M | $8.7M | $12.6M | $13.2M | $63.5M | $16.5M | $5.2M | $39.2M | $45.1M | $4.1M | $12.5M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$896.0K | -$1.3M | -$967.0K | -$563.0K | $1.9M | $4.0K | $29.0K | -$34.0K | -$41.0K | -$39.0K | -$45.0K | |
| Retained Earnings Accumulated Deficit | -$412.3M | -$397.0M | -$334.7M | -$307.7M | -$266.4M | -$223.1M | -$217.1M | -$170.5M | -$123.5M | -$67.9M | -$31.5M | |
| Property Plant And Equipment Net | $220.0K | $151.0K | $236.0K | $353.0K | $451.0K | $906.0K | $1.5M | $2.2M | $2.7M | $3.2M | $1.8M | |
| Prepaid Expense And Other Assets Current | $1.4M | $2.4M | $781.0K | $773.0K | $1.4M | $1.1M | $1.4M | $992.0K | $1.2M | $1.1M | $1.3M | |
| Liabilities Current | $9.4M | $35.4M | $6.9M | $10.8M | $9.7M | $12.1M | $10.2M | $7.0M | $9.0M | $5.9M | $3.1M | |
| Liabilities And Stockholders Equity | $71.1M | $68.9M | $45.6M | $68.2M | $109.5M | $85.5M | $83.6M | $118.2M | $94.8M | $140.2M | $98.5M | |
| Liabilities | $9.9M | $36.3M | $6.9M | $12.1M | $12.3M | $13.4M | $12.5M | $7.9M | $9.9M | $7.3M | $3.8M | |
| Assets Current | $58.2M | $54.4M | $28.0M | $43.7M | $71.3M | $45.3M | $79.3M | $115.6M | $91.2M | $136.0M | $95.7M | |
| Assets | $71.1M | $68.9M | $45.6M | $68.2M | $109.5M | $85.5M | $83.6M | $118.2M | $94.8M | $140.2M | $98.5M | |
| Accounts Payable Current | $2.5M | $2.6M | $1.5M | $2.0M | $1.6M | $3.5M | $2.4M | $2.0M | $3.5M | $1.9M | $1.6M | |
| Additional Paid In Capital Common Stock | $374.4M | $364.4M | $361.7M | $295.3M | $288.2M | $280.8M | $208.4M | $200.7M | $440.0K | |||
| Other Assets Noncurrent | $855.0K | $632.0K | $89.0K | $129.0K | $236.0K | $414.0K | $513.0K | $463.0K | $869.0K | $869.0K | ||
| Common Stock Value | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$4.2M | -$3.9M | -$539.0K | -$50.3M | $47.0M | $11.3M | -$34.0M | -$5.9M | $40.1M | $945.0K | ||
| Accrued Liabilities And Other Liabilities Current | $7.5M | $7.1M | $7.6M | $6.9M | $5.0M | $5.5M | $4.0M | $1.5M | ||||
| Available For Sale Securities Debt Securities | $14.5M | $29.1M | $6.0M | $27.8M | $72.8M | $75.4M | $44.9M | |||||
| Amortization Accretion Related To Marketable Securities | $239.0K | $154.0K | -$644.0K | -$608.0K | -$195.0K | $648.0K | -$41.0K | |||||
| Operating Lease Right Of Use Asset | $839.0K | $1.2M | $1.1M | $2.2M | $3.2M | $1.6M | $2.3M | $0.00 | ||||
| Operating Lease Liability Current | $403.0K | $185.0K | $1.4M | $1.2M | $1.0M | $1.1M | $878.0K | |||||
| Operating Lease Liability Noncurrent | $534.0K | $937.0K | $1.4M | $2.6M | $1.2M | $2.3M | ||||||
| Equity Method Investments | $11.0M | $12.5M | $16.1M | $21.9M | $34.3M | $37.2M | ||||||
| Equity Securities Fv Ni Realized Gain Loss | -$5.3M | -$10.0M | -$4.8M | -$234.0K | ||||||||
| Other Liabilities Noncurrent | $869.0K | $971.0K | $1.4M | $710.0K | ||||||||
| Accounts Receivable Net Current | $37.0K | $75.0K | $26.0K | $588.0K | ||||||||
| Cash And Cash Equivalents Period Increase Decrease | $40.1M | $945.0K | -$8.4M | $12.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $71.8M | $80.2M | $49.3M | $12.4M | $51.2M | $33.4M | $44.3M | $49.5M | $48.9M | $64.7M | $80.4M | $89.7M | $105.1M | $96.4M | $94.4M | $42.4M | $50.8M | $60.0M | $80.4M | $89.7M | $100.7M | $118.8M | $127.4M | $137.2M | $93.7M | $104.8M | $118.2M | $142.9M | $152.0M | $152.6M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.9M | $14.7M | $5.0M | $4.7M | $14.8M | $7.5M | $20.1M | $7.7M | $9.7M | $24.6M | $28.5M | $31.5M | $72.3M | $58.9M | $45.1M | $23.0M | $20.7M | $23.5M | $9.1M | $30.2M | $39.0M | $40.7M | $28.1M | $102.6M | $44.1M | $34.1M | ||||||||||
| Cash And Cash Equivalents At Carrying Value | $2.9M | $14.7M | $5.0M | $4.7M | $14.8M | $7.5M | $20.1M | $7.7M | $9.7M | $24.6M | $28.5M | $31.5M | $72.3M | $58.9M | $45.1M | $23.0M | $20.7M | $23.5M | $9.1M | $30.2M | $39.0M | $40.7M | $28.1M | $102.6M | $44.1M | $34.1M | $10.5M | $5.1M | $5.6M | $4.3M | $4.1M | $79.6M | $2.7M | $13.9M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.1M | -$1.1M | -$1.3M | -$738.0K | -$1.4M | -$1.3M | -$1.4M | -$1.4M | -$434.0K | -$1.2M | $339.0K | $2.0M | $1.4M | $1.4M | $6.0K | $12.0K | $53.0K | $43.0K | $34.0K | $39.0K | $11.0K | -$35.0K | -$20.0K | -$39.0K | -$14.0K | -$52.0K | -$62.0K | $41.0K | $78.0K | $29.0K | ||||||
| Retained Earnings Accumulated Deficit | -$400.0M | -$389.8M | -$381.8M | -$384.9M | -$344.7M | -$340.4M | -$328.1M | -$322.1M | -$315.6M | -$297.9M | -$283.0M | -$274.7M | -$257.1M | -$246.5M | -$234.7M | -$250.5M | -$240.7M | -$230.1M | -$206.1M | -$195.1M | -$182.1M | -$160.0M | -$149.5M | -$137.8M | -$111.6M | -$98.9M | -$83.9M | -$56.8M | -$46.5M | -$37.8M | ||||||
| Property Plant And Equipment Net | $221.0K | $249.0K | $165.0K | $171.0K | $192.0K | $213.0K | $264.0K | $294.0K | $330.0K | $447.0K | $527.0K | $364.0K | $539.0K | $647.0K | $769.0K | $1.0M | $1.1M | $1.3M | $1.6M | $1.8M | $2.0M | $2.2M | $2.3M | $2.5M | $2.9M | $3.0M | $3.1M | $2.9M | $2.8M | $2.6M | ||||||
| Prepaid Expense And Other Assets Current | $1.2M | $1.3M | $1.2M | $1.2M | $977.0K | $697.0K | $915.0K | $893.0K | $655.0K | $1.2M | $1.8M | $1.1M | $2.2M | $2.7M | $840.0K | $1.1M | $1.3M | $1.1M | $1.4M | $1.3M | $1.2M | $1.9M | $1.2M | $1.2M | $1.2M | $1.3M | $1.1M | $913.0K | $1.3M | $1.8M | ||||||
| Liabilities Current | $8.1M | $8.5M | $9.3M | $46.4M | $13.3M | $6.7M | $7.3M | $7.9M | $8.3M | $14.0M | $10.2M | $9.3M | $11.3M | $12.4M | $13.9M | $12.0M | $11.6M | $11.7M | $9.5M | $10.7M | $8.6M | $7.7M | $9.8M | $10.6M | $10.0M | $9.5M | $7.6M | $5.6M | $3.6M | $3.4M | ||||||
| Liabilities And Stockholders Equity | $80.5M | $89.5M | $59.4M | $58.8M | $64.6M | $40.1M | $51.9M | $58.0M | $58.2M | $80.3M | $92.5M | $101.3M | $119.3M | $109.4M | $109.2M | $55.9M | $64.2M | $73.8M | $92.5M | $103.1M | $112.3M | $127.2M | $137.9M | $148.7M | $104.8M | $115.5M | $127.1M | $149.8M | $156.9M | $157.2M | ||||||
| Liabilities | $8.7M | $9.2M | $10.1M | $46.4M | $13.3M | $6.7M | $7.7M | $8.6M | $9.3M | $15.7M | $12.2M | $11.6M | $14.2M | $13.0M | $14.9M | $13.5M | $13.3M | $13.8M | $12.1M | $13.5M | $11.6M | $8.4M | $10.5M | $11.5M | $11.1M | $10.7M | $8.9M | $6.9M | $5.0M | $4.7M | ||||||
| Assets Current | $66.9M | $75.8M | $45.5M | $42.9M | $48.3M | $22.9M | $33.1M | $37.9M | $35.6M | $51.3M | $58.9M | $64.4M | $78.8M | $69.1M | $68.8M | $52.5M | $60.6M | $69.8M | $87.8M | $98.1M | $107.0M | $124.5M | $134.4M | $145.2M | $100.9M | $111.6M | $123.1M | $146.0M | $153.5M | $154.1M | ||||||
| Assets | $80.5M | $89.5M | $59.4M | $58.8M | $64.6M | $40.1M | $51.9M | $58.0M | $58.2M | $80.3M | $92.5M | $101.3M | $119.3M | $109.4M | $109.2M | $55.9M | $64.2M | $73.8M | $92.5M | $103.1M | $112.3M | $127.2M | $137.9M | $148.7M | $104.8M | $115.5M | $127.1M | $149.8M | $156.9M | $157.2M | ||||||
| Accounts Payable Current | $2.0M | $3.1M | $1.3M | $1.9M | $1.2M | $1.6M | $1.4M | $2.1M | $1.4M | $4.2M | $2.7M | $2.2M | $2.3M | $2.9M | $4.9M | $2.6M | $2.8M | $3.4M | $1.9M | $2.6M | $2.3M | $1.9M | $2.3M | $3.5M | $3.6M | $4.1M | $2.4M | $2.4M | $1.3M | $1.6M | ||||||
| Additional Paid In Capital Common Stock | $472.8M | $471.2M | $432.4M | $430.9M | $398.0M | $397.3M | $375.1M | $373.8M | $372.9M | $364.9M | $363.7M | $363.1M | $362.4M | $360.9M | $341.5M | $329.1M | $292.8M | $291.5M | $290.1M | $286.5M | $284.7M | $282.8M | $278.8M | $276.9M | $275.1M | $205.4M | $203.7M | $202.2M | $199.7M | $198.4M | $190.4M | |||||
| Other Assets Noncurrent | $852.0K | $626.0K | $629.0K | $252.0K | $129.0K | $89.0K | $89.0K | $129.0K | $129.0K | $248.0K | $236.0K | $236.0K | $279.0K | $316.0K | $1.1M | $480.0K | $501.0K | $513.0K | $513.0K | $513.0K | $514.0K | $464.0K | $1.2M | $1.1M | $1.1M | $869.0K | $869.0K | $869.0K | $619.0K | $600.0K | ||||||
| Common Stock Value | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.7M | -$5.2M | -$3.5M | -$32.0M | $28.6M | $18.3M | -$220.0K | $57.5M | ||||||||||||||||||||||||||||
| Accrued Liabilities And Other Liabilities Current | $4.2M | $4.3M | $4.1M | $4.0M | $4.6M | $4.5M | $5.6M | $8.6M | $6.4M | $6.0M | $8.0M | $8.3M | $7.9M | $8.4M | $7.8M | $7.4M | $6.8M | $7.2M | $5.6M | $5.9M | $7.5M | $7.1M | $6.4M | $5.4M | $5.2M | $3.2M | $2.3M | $1.8M | ||||||||
| Available For Sale Securities Debt Securities | $62.8M | $59.7M | $39.2M | $43.2M | $37.0M | $32.4M | $14.7M | $12.1M | $29.4M | $24.8M | $25.0M | $28.2M | $31.5M | $4.0M | $7.5M | $22.9M | $28.4M | $38.6M | $45.2M | $77.4M | $66.7M | $66.8M | $81.9M | $105.2M | $41.4M | |||||||||||
| Amortization Accretion Related To Marketable Securities | $55.0K | $95.0K | -$64.0K | -$170.0K | -$44.0K | -$19.0K | $105.0K | |||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $927.0K | $1.0M | $1.1M | $284.0K | $578.0K | $865.0K | $1.4M | $1.7M | $2.0M | $2.5M | $2.7M | $3.0M | $3.4M | $1.3M | $1.5M | $1.8M | $2.0M | $2.2M | $2.5M | $2.6M | $2.8M | |||||||||||||||
| Operating Lease Liability Current | $379.0K | $355.0K | $319.0K | $354.0K | $700.0K | $1.0M | $1.3M | $1.3M | $1.3M | $1.2M | $1.1M | $1.1M | $1.0M | $1.2M | $1.1M | $1.0M | $976.0K | $927.0K | $849.0K | $820.0K | $792.0K | |||||||||||||||
| Operating Lease Liability Noncurrent | $632.0K | $728.0K | $834.0K | $354.0K | $700.0K | $1.0M | $1.7M | $2.0M | $2.3M | $2.9M | $631.0K | $935.0K | $1.5M | $1.8M | $2.1M | $2.5M | $2.8M | $3.0M | ||||||||||||||||||
| Equity Method Investments | $11.5M | $11.8M | $12.1M | $15.2M | $15.4M | $16.1M | $17.1M | $18.0M | $20.2M | $25.9M | $30.2M | $33.4M | $36.3M | $38.0M | $37.1M | |||||||||||||||||||||
| Equity Securities Fv Ni Realized Gain Loss | -$865.0K | -$1.3M | -$1.7M | -$2.7M | -$1.6M | -$1.0M | -$1.7M | -$463.0K | -$100.0K | |||||||||||||||||||||||||||
| Other Liabilities Noncurrent | $627.0K | $741.0K | $857.0K | $1.1M | $1.2M | $1.3M | $1.3M | $1.3M | $1.3M | |||||||||||||||||||||||||||
| Accounts Receivable Net Current | $32.0K | $86.0K | $79.0K | $70.0K | $35.0K | $26.0K | $11.0K | |||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $57.5M | $5.4M | -$40.0K | $1.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $36.4M | $49.0M | $7.9M | $0.00 | $62.2M | $1.3M | $24.0K | $65.3M | $1.4M | $71.4M | $94.9M | $12.6M |
| Investing Cash Flow * | -$7.8M | -$27.5M | $15.5M | -$23.3M | $21.6M | $44.8M | $3.3M | -$30.2M | $84.8M | -$42.6M | -$92.0M | |
| Operating Cash Flow * | -$32.8M | -$25.4M | -$23.9M | -$27.0M | -$36.7M | -$34.8M | -$37.3M | -$41.0M | -$46.2M | -$27.9M | -$11.3M | -$96.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$941.0K | $1.6M | $8.0K | -$581.0K | $277.0K | -$285.0K | $370.0K | -$187.0K | $44.0K | -$290.0K | $1.3M | $12.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $2.8M | -$245.0K | -$3.6M | $467.0K | -$523.0K | $705.0K | $2.0M | -$560.0K | $1.5M | $2.8M | $1.2M | $17.0K |
| Increase Decrease In Accounts Payable | -$91.0K | $1.1M | -$451.0K | $411.0K | -$1.9M | $1.0M | $450.0K | -$1.5M | $1.6M | $518.0K | $1.2M | $57.0K |
| Share Based Compensation | $5.3M | $3.0M | $2.1M | $2.7M | $4.2M | $5.7M | $7.3M | $7.1M | $6.2M | $3.8M | $428.0K | |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $84.1M | $42.6M | $62.6M | $43.2M | $30.9M | $86.4M | $141.9M | $132.0M | $173.4M | $213.7M | $14.1M | |
| Depreciation Depletion And Amortization | $105.0K | $85.0K | $151.0K | $367.0K | $460.0K | $632.0K | $743.0K | $847.0K | $842.0K | $594.0K | $148.0K | |
| Payments To Acquire Available For Sale Securities Debt | $91.8M | $70.1M | $47.0M | $66.2M | $9.4M | $42.5M | $138.6M | $161.9M | $88.3M | $258.3M | ||
| Payments To Acquire Property Plant And Equipment | $174.0K | $34.0K | $269.0K | $5.0K | $76.0K | $25.0K | $355.0K | $266.0K | $2.2M | $1.7M | ||
| Increase Decrease In Other Noncurrent Assets | -$338.0K | $28.0K | -$1.1M | -$973.0K | -$178.0K | -$99.0K | $50.0K | -$406.0K | $869.0K | |||
| Proceeds From Stock Options Exercised | $684.0K | $68.0K | $12.0K | $1.2M | $88.0K | $24.0K | $393.0K | $731.0K | $4.0K | $108.0K | ||
| Increase Decrease In Operating Lease Right Of Use Asset | $1.1M | $973.0K | -$1.5M | $679.0K | $599.0K | |||||||
| Increase Decrease In Operating Lease Liabilities | $1.2M | $1.0M | -$1.3M | $878.0K | $767.0K | |||||||
| Proceeds From Issuance Of Common Stock | $16.4M | $32.0M | $64.9M | $711.0K | $71.4M | |||||||
| Increase Decrease In Accounts Receivable Related Parties | $49.0K | -$562.0K | $81.0K | $507.0K | ||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $12.0K | $28.0K | $28.0K | $34.0K | ||||||||
| Increase Decrease In Other Noncurrent Liabilities | $12.0K | -$102.0K | -$434.0K | $695.0K | $639.0K | $3.0K | ||||||
| Proceeds From Issuance Of Common Stock Related Party | $1.8M | $4.9M | $30.9M | $34.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q3 2021 | Q1 2021 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $279.0K | $4.0K | $32.6M | $1.0K | $64.9M | $8.0K | $64.3M | $4.0M | ||||||||
| Investing Cash Flow * | $4.2M | -$7.0K | $4.6M | -$25.6M | $4.8M | $27.7M | $8.8M | $3.6M | $18.2M | -$58.7M | -$324.0K | |||||
| Operating Cash Flow * | -$8.3M | -$5.2M | -$8.1M | -$6.4M | -$8.8M | -$9.4M | -$9.0M | -$11.0M | -$12.7M | -$5.6M | -$2.3M | |||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.2M | -$84.0K | -$118.0K | -$304.0K | -$237.0K | -$226.0K | $205.0K | $53.0K | -$63.0K | $347.0K | $198.0K | |||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $146.0K | $101.0K | -$1.9M | -$1.1M | $287.0K | $530.0K | $714.0K | $1.6M | $1.1M | $618.0K | $75.0K | |||||
| Increase Decrease In Accounts Payable | -$1.3M | $84.0K | -$569.0K | $624.0K | $1.4M | $908.0K | $266.0K | $45.0K | $559.0K | -$193.0K | $29.0K | |||||
| Share Based Compensation | $1.3M | $689.0K | $492.0K | $739.0K | $1.2M | $1.8M | $2.0M | $1.8M | $1.5M | $441.0K | $2.0K | |||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $12.0M | $4.6M | $17.7M | $810.0K | $8.2M | $38.1M | $38.7M | $19.4M | $36.3M | $33.0M | ||||||
| Depreciation Depletion And Amortization | $22.0K | $23.0K | $57.0K | $87.0K | $137.0K | $184.0K | $186.0K | $219.0K | $204.0K | |||||||
| Payments To Acquire Available For Sale Securities Debt | $7.7M | $4.6M | $13.1M | $26.4M | $3.3M | $11.4M | $29.9M | $15.8M | $18.0M | |||||||
| Payments To Acquire Property Plant And Equipment | $36.0K | $34.0K | $16.0K | $6.0K | $111.0K | $614.0K | $324.0K | |||||||||
| Increase Decrease In Other Noncurrent Assets | -$82.0K | -$284.0K | $664.0K | $51.0K | $194.0K | $600.0K | -$20.0K | |||||||||
| Proceeds From Stock Options Exercised | $279.0K | $4.0K | $1.0K | $7.0K | $8.0K | $42.0K | ||||||||||
| Increase Decrease In Operating Lease Right Of Use Asset | $284.0K | $264.0K | $238.0K | $2.4M | $193.0K | -$164.0K | -$146.0K | |||||||||
| Increase Decrease In Operating Lease Liabilities | $334.0K | $298.0K | $254.0K | $2.4M | $260.0K | -$211.0K | -$186.0K | |||||||||
| Proceeds From Issuance Of Common Stock | $32.0M | $64.9M | $64.3M | |||||||||||||
| Increase Decrease In Accounts Receivable Related Parties | $4.0K | -$159.0K | -$134.0K | |||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $3.0K | $4.0K | $5.0K | $7.0K | $6.0K | $7.0K | ||||||||||
| Increase Decrease In Other Noncurrent Liabilities | -$115.0K | -$108.0K | $581.0K | |||||||||||||
| Proceeds From Issuance Of Common Stock Related Party | $4.9M | $30.9M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.53 | -$1.02 | -$0.56 | -$0.89 | -$1.03 | -$0.20 | -$1.59 | -$1.71 | -$2.72 | -$2.36 | -$83.86 | -$0.95 |
| Common Stock Shares Outstanding | 74.7M | 67.9M | 49.0M | 46.6M | 28.4M | 28.0M | 29.3M | 21.0M | 20.9M | 1.4M | ||
| Common Stock Shares Issued | 74.7M | 67.9M | 49.0M | 46.6M | 28.4M | 28.0M | 29.3M | 21.0M | 20.9M | 1.4M | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 20.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 29.5M | 29.3M | 27.5M | 20.5M | 15.4M | 373.6K | 170.3K | |||||
| Earnings Per Share Basic | $-0.19 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | |||||
| Weighted Average Number Of Shares Outstanding Basic | 79.0M | 61.0M | 48.0M | 46.6M | 41.9M | 29.5M | 29.3M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 79.7M | 61.0M | 48.0M | 46.6M | 41.9M | 29.5M | 29.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | -$0.10 | -$0.13 | -$0.60 | -$0.07 | -$0.12 | -$0.12 | -$0.14 | -$0.17 | -$0.32 | -$0.18 | -$0.18 | -$0.20 | -$0.24 | -$0.28 | -$0.34 | $0.92 | -$0.33 | -$0.36 | -$0.44 | $0.92 | -$0.33 | -$0.36 | -$0.44 | -$0.36 | -$0.36 | -$0.40 | -$0.63 | -$0.58 | -$0.62 | -$0.73 | -$0.79 | -$0.55 | -$0.51 | -$0.43 | -$5.39 | -$13.31 | -$7.97 | -$58.42 | -$6.44 | ||
| Common Stock Shares Outstanding | 74.7M | 74.5M | 68.2M | 62.6M | 62.6M | 49.0M | 49.0M | 48.9M | 46.6M | 46.6M | 46.6M | 46.6M | 46.6M | 46.5M | 42.4M | 38.3M | 28.1M | 28.0M | 28.0M | 29.4M | 29.3M | 29.3M | 29.3M | 29.2M | 29.2M | 20.9M | 20.9M | 20.9M | 20.9M | 20.9M | 20.4M | |||||||||||
| Common Stock Shares Issued | 74.7M | 74.5M | 68.2M | 62.6M | 62.6M | 49.0M | 49.0M | 48.9M | 46.6M | 46.6M | 46.6M | 46.6M | 46.6M | 46.5M | 42.4M | 38.3M | 28.1M | 28.0M | 28.0M | 29.4M | 29.3M | 29.3M | 29.3M | 29.2M | 29.2M | 20.9M | 20.9M | 20.9M | 20.9M | 20.9M | 20.4M | |||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Common Stock Shares Authorized | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | ||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 43.9M | 42.2M | 34.5M | 29.5M | 29.4M | 29.4M | 29.4M | 29.3M | 29.3M | 29.1M | 29.0M | 22.6M | 20.5M | 20.4M | 20.3M | 20.2M | 20.0M | 1.2M | 395.3K | 346.3K | 297.1K | |||||||||||||||||||||
| Earnings Per Share Basic | $-0.12 | $-0.10 | $0.21 | $-0.60 | $-0.07 | $-0.12 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | $-0.18 | $-0.20 | $-0.24 | $-0.28 | $-0.34 | $0.92 | $-0.33 | $-0.36 | $-0.44 | ||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 82.8M | 77.8M | 72.1M | 66.7M | 59.7M | 49.0M | 49.0M | 47.5M | 46.6M | 46.6M | 46.6M | 46.6M | 43.9M | 42.2M | 34.5M | |||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 82.8M | 77.8M | 75.2M | 66.7M | 59.7M | 49.0M | 49.0M | 47.5M | 46.6M | 46.6M | 46.6M | 46.6M | 43.9M | 42.2M | 34.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.3M | $3.0M | $2.1M | $2.7M | $4.2M | $5.7M | $7.3M | $7.1M | $6.2M | $3.8M | $428.0K | |
| Interest Income And Other Expense Net | $1.6M | $654.0K | -$15.0K | $540.0K | $2.2M | $2.3M | $861.0K | $601.0K | $35.0K | |||
| Stock Issued During Period Value Stock Options Exercised | $684.0K | $68.0K | $12.0K | $1.2M | $88.0K | $24.0K | $393.0K | $731.0K | $4.0K | |||
| Sublease Income Related Party | $78.0K | $587.0K | $235.0K | |||||||||
| Capital Expenditures Incurred But Not Yet Paid | $5.0K | $84.0K | $84.0K | $286.0K | ||||||||
| Costs And Expenses | $37.0M | $13.8M | $161.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.2M | $1.3M | $1.3M | $733.0K | $768.0K | $689.0K | $546.0K | $537.0K | $492.0K | $658.0K | $675.0K | $739.0K | $1.1M | $1.2M | $1.2M | $1.3M | $1.4M | $1.8M | $1.7M | $1.9M | $2.0M | $1.8M | $1.7M | $1.8M | |||||||||||
| Interest Income And Other Expense Net | $566.0K | $434.0K | $316.0K | $425.0K | $403.0K | $376.0K | $225.0K | $100.0K | $11.0K | -$11.0K | $1.0K | $3.0K | $49.0K | $156.0K | $334.0K | $509.0K | $618.0K | $662.0K | $651.0K | $627.0K | $343.0K | $227.0K | $193.0K | $179.0K | -$31.0K | ||||||||||
| Stock Issued During Period Value Stock Options Exercised | $360.0K | $25.0K | $279.0K | $50.0K | $8.0K | $4.0K | $1.2M | $64.0K | $23.0K | $16.0K | $5.0K | $1.0K | $159.0K | $41.0K | $7.0K | ||||||||||||||||||||
| Sublease Income Related Party | $56.0K | $147.0K | $146.0K | $146.0K | $94.0K | ||||||||||||||||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $16.0K | $46.0K | $199.0K | $60.0K | |||||||||||||||||||||||||||||||
| Costs And Expenses | $14.6M | $12.9M | $15.2M | $16.2M | $11.2M | $10.5M | $8.8M | $6.4M | $6.1M | $3.1M | $2.3M | $2.2M |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.